Institutions / AIGH Capital Management LLC / Activity
Activity — AIGH Capital Management LLC
54 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | New | Nn Inc Common stock | $41.3K | +11K | 11,496 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | Talphera, Inc. Common stock | $-61.8K | -60K -1.29% | 4,601,502 0.43% of portfolio | low |
| Q2 2026 as of | Add | Quoin Pharmaceuticals Ltd. Common stock | $100.1K | +21K +41.92% | 70,000 0.03% of portfolio | low |
| Q2 2026 as of | Add | APYX Apyx Medical Corp Common Stock | $104.9K | +23K +2.12% | 1,128,343 0.46% of portfolio | low |
| Q2 2026 as of | Trim | BFRI Biofrontera Inc. Common Stock | $-165.7K | -175K -19.15% | 739,910 0.06% of portfolio | low |
| Q2 2026 as of | Add | Vanda Pharmaceuticals Inc Common stock | $279.9K | +46K +2.29% | 2,044,169 1.13% of portfolio | low |
| Q2 2026 as of | Trim | ELUT Elutia Inc. Common Stock | $-364.9K | -373K -12.14% | 2,695,644 0.24% of portfolio | low |
| Q2 2026 as of | Add | APRE Aprea Therapeutics, Inc. Common Stock | $517.5K | +645K +174.07% | 1,015,541 0.07% of portfolio | low |
| Q2 2026 as of | Exit | 83193D203 Common stock | $-718.9K | -675K -100.00% | 0 | low |
| Q2 2026 as of | Add | M8001Q126 Common stock | $821.8K | +162K +12.05% | 1,504,741 0.69% of portfolio | low |
| Q2 2026 as of | Add | Neuraxis, INC Common stock | $876.7K | +120K +29.98% | 519,938 0.34% of portfolio | low |
| Q2 2026 as of | Add | RenovoRx, Inc. Common stock | $1.54M | +1.6M +55.46% | 4,405,439 0.39% of portfolio | low |
| Q2 2026 as of | Trim | Castle Biosciences, Inc. Common stock | $-1.90M | -80K -12.74% | 545,101 1.18% of portfolio | low |
| Q2 2026 as of | Trim | COYA Coya Therapeutics, Inc. Common Stock | $-2.01M | -343K -35.22% | 631,912 0.33% of portfolio | low |
| Q2 2026 as of | Add | Ideal Power Inc. Common stock | $2.16M | +403K +81.86% | 894,731 0.43% of portfolio | low |
| Q2 2026 as of | Exit | Grace Therapeutics, Inc. Common stock | $-3.15M | -907K -100.00% | 0 | low |
| Q2 2026 as of | New | Identiv, Inc. Common stock | $3.65M | +1.4M | 1,449,121 0.33% of portfolio | low |
| Q2 2026 as of | New | Richardson Electronics, Ltd. Common stock | $3.81M | +200K | 200,434 0.34% of portfolio | low |
| Q2 2026 as of | New | Energous Corporation Common stock | $4.38M | +182K | 182,000 0.40% of portfolio | low |
| Q2 2026 as of | New | Tigo Energy, Inc. Common stock | $4.64M | +2.0M | 1,990,371 0.42% of portfolio | low |
| Q2 2026 as of | New | KIDS Orthopediatrics Corp Common Stock | $5.16M | +270K | 269,765 0.47% of portfolio | medium |
| Q2 2026 as of | New | AEye, Inc. Common stock | $5.55M | +3.9M | 3,855,000 0.50% of portfolio | medium |
| Q2 2026 as of | New | BWEN Broadwind, Inc. Common Stock | $5.58M | +1.2M | 1,156,000 0.51% of portfolio | medium |
| Q2 2026 as of | Add | Abeona Therapeutics Inc. Common stock | $6.10M | +987K +49.35% | 2,987,000 1.67% of portfolio | medium |
| Q2 2026 as of | Exit | Byrna Technologies Inc. Common stock | $-6.63M | -395K -100.00% | 0 | medium |
| Q2 2026 as of | New | Verastem, Inc. Common stock | $7.36M | +1.9M | 1,927,000 0.67% of portfolio | medium |
| Q2 2026 as of | Exit | Arq, Inc. Common stock | $-7.43M | -2.3M -100.00% | 0 | medium |
| Q2 2026 as of | Exit | Larimar Therapeutics, Inc. Common stock | $-7.62M | -2.0M -100.00% | 0 | medium |
| Q2 2026 as of | Exit | Intellicheck Inc Common stock | $-8.11M | -1.2M -100.00% | 0 | medium |
| Q2 2026 as of | New | PTHS Pelthos Therapeutics Inc. Common Stock | $9.30M | +329K | 329,098 0.84% of portfolio | medium |
| Q2 2026 as of | Add | Fennec Pharmaceuticals Inc. Common stock | $9.72M | +905K +57.19% | 2,486,038 2.42% of portfolio | medium |
| Q2 2026 as of | Add | Ardelyx, Inc. Common stock | $10.46M | +2.0M +178.26% | 3,200,000 1.48% of portfolio | medium |
| Q2 2026 as of | Exit | LPTH Lightpath Technologies Inc Common Stock | $-11.13M | -1.0M -100.00% | 0 | medium |
| Q2 2026 as of | Add | KYTX Kyverna Therapeutics, Inc. Common Stock | $11.55M | +1.3M +86.39% | 2,795,797 2.26% of portfolio | medium |
| Q2 2026 as of | New | SPRB Spruce Biosciences, Inc. Common Stock | $13.50M | +250K | 250,000 1.22% of portfolio | medium |
| Q2 2026 as of | Exit | Esperion Therapeutics, Inc. Common stock | $-14.80M | -4.0M -100.00% | 0 | medium |
| Q2 2026 as of | New | Biodesix, Inc. Common stock | $15.30M | +678K | 678,328 1.38% of portfolio | medium |
| Q2 2026 as of | Exit | Domo, Inc. Common stock | $-15.49M | -1.8M -100.00% | 0 | medium |
| Q2 2026 as of | Exit | BK Technologies Corp Common stock | $-15.77M | -211K -100.00% | 0 | medium |
| Q2 2026 as of | Trim | PSNL Personalis, Inc. Common Stock | $-15.88M | -1.2M -40.86% | 1,715,000 2.08% of portfolio | medium |
| Q2 2026 as of | Exit | Day One Biopharmaceuticals, Inc. Common stock | $-18.57M | -2.0M -100.00% | 0 | medium |
| Q2 2026 as of | New | VUZI Vuzix Corp Common Stock | $19.56M | +6.7M | 6,745,667 1.77% of portfolio | medium |
| Q2 2026 as of | New | DDD 3D Systems Corp Common Stock | $21.96M | +7.3M | 7,271,000 1.99% of portfolio | medium |
| Q2 2026 as of | Exit | Nlight, Inc. Common stock | $-22.51M | -600K -100.00% | 0 | medium |
| Q2 2026 as of | New | H82027105 Common stock | $22.82M | +4.0M | 3,954,194 2.07% of portfolio | medium |
| Q2 2026 as of | New | Nyxoah SA Common stock | $24.56M | +14.5M | 14,534,880 2.22% of portfolio | medium |
| Q2 2026 as of | New | ASYS Amtech Systems Inc Common Stock | $28.90M | +1.3M | 1,252,000 2.62% of portfolio | medium |
| Q2 2026 as of | New | Methode Electronics Inc Common stock | $31.84M | +1.7M | 1,678,409 2.88% of portfolio | medium |
| Q2 2026 as of | New | Clearfield, Inc. Common stock | $40.13M | +1.0M | 1,008,469 3.63% of portfolio | medium |
| Q2 2026 as of | New | SIMO Silicon Motion Technology CORP ADR | $48.00M | +144K | 144,000 4.35% of portfolio | medium |